Kon Chu

Medicine & Life Sciences

1. Cerebral Hemorrhage 100%
2. Seizures 94%
3. Epilepsy 93%
4. Neural Stem Cells 86%
5. Stroke 85%
6. Huntington Disease 83%
7. Encephalitis 83%
8. Brain 72%
9. Hashimoto's encephalitis 67%
10. Status Epilepticus 64%
11. Stem Cells 46%
12. Immunotherapy 44%
13. Stem Cell Transplantation 41%
14. Alzheimer Disease 41%
15. REM Sleep Behavior Disorder 40%
16. Temporal Lobe Epilepsy 39%
17. MicroRNAs 38%
18. Oxcarbazepine 37%
19. Therapeutics 37%
20. Anti-N-Methyl-D-Aspartate Receptor Encephalitis 36%
21. Brain Ischemia 36%
22. Ischemia 35%
23. Pilocarpine 33%
24. Electroencephalography 32%
25. Levetiracetam 32%
26. White Matter 29%
27. Neuroprotective Agents 29%
28. Endothelial Progenitor Cells 28%
29. Antibodies 28%
30. Corpus Striatum 28%
31. Brain Diseases 27%
32. Celecoxib 26%
33. Panax 26%
34. Postural Orthostatic Tachycardia Syndrome 26%
35. Rituximab 26%
36. Transplantation 25%
37. Granulocyte Colony-Stimulating Factor 25%
38. Cell Death 24%
39. Drug Resistant Epilepsy 24%
40. ATP Binding Cassette Transporter, Subfamily B, Member 1 23%
41. Orthostatic Intolerance 23%
42. 3-nitropropionic acid 23%
43. HLA Antigens 23%
44. Memantine 22%
45. Long Noncoding RNA 22%
46. Anticonvulsants 22%
47. Cerebrospinal Fluid 22%
48. Theoretical Models 22%
49. Brain Edema 21%
50. Partial Epilepsy 21%